Psychedelic Science Update

Psychedelic Science

June 19-23, 2023, the largest psychedelic conference in history on Psychedelic Science, sponsored by MAPS, was attended by more than 12,000 people in Denver, CO. You can attend virtually with pre-recorded sessions highlighting key themes of the conference. This Virtual Trip will eventually contain nearly all recorded sessions. Click HERE for access, offered via a “pay what you can” model.

September 21-23, Stowe, VT: An extraordinary conference on Psychedelic Science and Spirituality called Soulquinox was created by the Psychedelic Society of Vermont.

Community Support

Ros Watts, PhD, began Friday morning asserting that the collective culture we are in is not conducive to creating community that supports expanded states of consciousness. Therefore, we need to create community to serve those who are exploring through psychedelic-assisted psychotherapy (PAP) or on their own. Sustaining the breakthroughs happens over time through community and supportive relationships.

What The Science Tells Us

Gül Dölen, MD, PhD, illustrated how psychedelics create “critical periods” during and shortly after taking them, offering enhanced neuroplasticity in the brain making it easier to heal both emotionally and physically. Ben Sessa, MD, reviewed recent studies illustrating how psychedelics have proven to effectively help heal depression, anxiety, PTSD and addiction.

The Future of Psychedelic Science

Janice Phelps, PhD, reviewed the need for extensive training of responsible guides. Rick Doblin, PhD, President of MAPS, determined that in late 2024 we could see the federal legalization of MDMA for use in psychotherapy.

Author: Emma Bragdon, PhD, is the Executive Director of Integrative Mental Health University. IMHU offers several courses on Psychedelic-Assisted Psychotherapy. Check out all IMHU courses by clicking HERE.